In trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 6.1% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 22.5% and shares of Prime Medicine, up about 19.3% on
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.